MORRISVILLE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today released its Dealmakers™ Intentions Survey. Conducted...
MORRISVILLE, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today released its 2024 Health Trends “ The Big Leap: The...
Odyssey Selects Syneos to Support NDA for Treatment of Concussion
Syneos Health today appointed Collin Shannon as its new CEO. Michelle Keefe remains on Company Board and member of its executive leadership team.
MORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (œSyneos Health or the œCompany), a leading fully integrated biopharmaceutical solutions organization, today announced the...
MORRISVILLE, N.C., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, has announced the appointment of Terttu...
MORRISVILLE, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic collaboration...
MORRISVILLE, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Star Parent, Inc. (the œIssuer or the œCompany) and Syneos Health, Inc. (œSyneos Health), announced today that, subject to market conditions...
MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (€œSyneos Health€ or the €œCompany€), a leading fully integrated biopharmaceutical solutions organization, today...
The contract research organization Syneos Health didn’t hold up its end of the deal and use “commercially reasonable efforts” when setting up a trial for a biotech client, an arbitration panel found. It also determined that the client owes the CRO about $1.7 million in damages — less than half of what Syneos was asking for in payment.